Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The joint venture will be settled in the Haikou National High-tech Zone of south China's Hainan Province, and will focus on research in regenerative medicine and cell culture medium, mesenchymal stem cells-based therapies, as well as related commercial operation.
Lead Product(s): Mesenchymal Stem Cells-based Therapy
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: PreclinicalProduct Type: Cell and Gene therapy
Recipient: Bloomage Biotechnology Corp., Ltd
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership June 24, 2022